Medicare Enrolled

Dr. Jesus Penabad, M.D.

Endocrinology · Hudson, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
14100 FIVAY RD, Hudson, FL 34667
7278697822
In practice since 2005 (20 years)
NPI: 1285637553 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Penabad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Penabad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Penabad

Dr. Jesus Penabad is an endocrinology in Hudson, FL, with 20 years in practice. Based on federal Medicare data, Dr. Penabad performed 16,060 Medicare services across 1,514 unique beneficiaries.

Between the years covered by Open Payments, Dr. Penabad received a total of $36,432 from 58 pharmaceutical and/or device companies across 778 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Penabad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in FL$ $36,432 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,060
Medicare services
Top 5% in FL for endocrinology
1,514
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~803 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Romosozumab injection (Evenity) for osteoporosis10,290$8$12
Denosumab injection (Prolia/Xgeva)3,420$18$30
Office visit, established patient (30-39 min)779$91$214
Blood glucose (sugar) test performed by hand-held instrument453$3$9
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report339$26$86
Drug injection, under skin or into muscle174$10$51
Ultrasound scan of head and neck soft tissue140$82$244
Office visit, established patient (20-29 min)135$68$146
Office visit, established patient, complex (40-54 min)95$135$287
Hospital follow-up visit, low complexity59$39$78
New patient office visit (45-59 min)49$116$333
Diabetes outpatient self-management training services, individual, per 30 minutes40$39$105
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional31$16$50
New patient office visit, complex (60-74 min)21$137$412
Fine needle aspiration biopsy using ultrasound guidance, first growth19$108$282
Initial hospital admission, moderate complexity16$105$276
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$36,432
Total received (2018-2024)
Avg $5,205/year across 7 years
Top 12% in FL for endocrinology
58
Companies
778
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,216 (58.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,216 (41.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,908
2023
$2,265
2022
$2,782
2021
$1,069
2020
$3,395
2019
$10,767
2018
$14,247

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$19,366
Novo Nordisk Inc
$2,234
Amgen Inc.
$1,823
PFIZER INC.
$1,334
Lilly USA, LLC
$1,244
SANOFI-AVENTIS U.S. LLC
$1,110
Corcept Therapeutics
$908
Tandem Diabetes Care, Inc.
$816
Abbott Laboratories
$644
AstraZeneca Pharmaceuticals LP
$629
Merck Sharp & Dohme Corporation
$480
Insulet Corporation
$455
Amarin Pharma Inc.
$433
Dexcom, Inc.
$431
Boehringer Ingelheim Pharmaceuticals, Inc.
$404
Radius Health, Inc.
$372
Bayer HealthCare Pharmaceuticals Inc.
$331
Xeris Pharmaceuticals, Inc.
$303
Bayer Healthcare Pharmaceuticals Inc.
$279
Medtronic MiniMed, Inc.
$278
RECORDATI_RARE_DISEASES_INC.
$215
Medtronic, Inc.
$201
Esperion Therapeutics, Inc.
$188
Valeritas, Inc.
$175
BETA BIONICS, INC.
$164
Senseonics, Incorporated
$140
IBSA Pharma Inc.
$135
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$118
Amneal Pharmaceuticals LLC
$103
Ipsen Biopharmaceuticals, Inc
$96
Nevro Corp.
$82
Kowa Pharmaceuticals America, Inc.
$72
Merck Sharp & Dohme LLC
$60
LIFESCAN, INC.
$58
Ascensia Diabetes Care Us Inc.
$55
Kyowa Kirin, Inc.
$55
AbbVie, Inc.
$54
Zealand Pharma US, Inc.
$50
Shire North American Group Inc
$50
Antares Pharma, Inc.
$44
LifeScan, Inc.
$43
Lexicon Pharmaceuticals, Inc.
$42
Mannkind Corporation
$41
Horizon Therapeutics plc
$36
Companion Medical, Inc.
$35
Neurocrine Biosciences, Inc.
$29
EUSA Pharma (US) LLC
$24
Renalytix AI, Inc.
$23
AbbVie Inc.
$21
Echosens North America, Inc.
$20
Averitas Pharma Inc.
$19
MannKind Corporation
$18
Sun Pharmaceutical Industries Inc.
$16
Regeneron Healthcare Solutions, Inc.
$16
Organogenesis Inc.
$16
Orexigen Therapeutics, Inc.
$15
Novartis Pharmaceuticals Corporation
$14
OPKO Pharmaceuticals, LLC
$12
Top 3 companies account for 64.3% of total payments
Associated products mentioned in payments ›
AFREZZA · Apligraf · BAQSIMI · BASAGLAR · BYDUREON · CONTRAVE · CYCLOSET · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FibroScan · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · ISTURISA · InPen · Inpefa · JANUVIA · JARDIANCE · KEVEYIS · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Livalo · MINIMED 780G · MOUNJARO · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · ONETOUCH VERIO FLEX · OT Verio Flex Starter Kit · Omnia · Omnipod · OneTouch · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · RECORLEV · RIOMET ER · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Senza · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $227 per 100 Medicare services performed
Looking for a endocrinology in Hudson?
Compare endocrinologys in the Hudson area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
26
Per 100K population
4.4
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Penabad is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (speaking/promotional, top 12%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Penabad experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Penabad performed 10,290 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Penabad receive payments from pharmaceutical companies?
Yes. Dr. Penabad received a total of $36,432 from 58 companies across 778 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Penabad's costs compare to other endocrinologys in Hudson?
Dr. Penabad's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Penabad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →